查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1197352

IV 极市场 - 增长、趋势、COVID-19 影响和预测 (2023-2028)

Iv Poles Market - Growth, Trends, and Forecasts (2023 - 2028)
出版日期: | 出版商: Mordor Intelligence | 英文 110 Pages | 商品交期: 2-3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

在预测期内，IV 极市场预计将以 6.3% 的复合年增长率增长。

COVID-19 大流行在短期内对市场产生了负面影响，因为早期患者到医院和诊所就诊的人数有所下降。 然而，在大流行的后期阶段，对研究和临床试验的需求增加，以了解静脉注射和补充剂是否会使受感染患者的 COVID-19 症状恶化。 例如，NIH 于 2022 年 9 月更新的 COVID-19 治疗指南建议，在巴基斯坦一项针对重症 COVID-19 住院患者的开放标籤试验中，将维生素 C（50 mg/kg/天）添加到标准疗法中。当静脉内给予或随机接受标准疗法（如解热药、地塞米鬆或预防性抗生素）时，接受维生素 C 的患者比仅接受标准疗法的患者改善更快，住院时间更短。有人提到 因此，大流行期间的这些事件创造了对 IV 治疗的需求，从而创造了 IV Pole 市场机会。 因此，由于上述因素和情况，COVID-19 大流行对研究市场产生了重大影响。

癌症、神经系统疾病和胃肠道疾病等慢性病的增加以及老年人口的增加等因素正在促进输液架市场的增长。

全球人口正在老龄化，最终增加了疾病负担。 多项研究表明，超过 20% 的老年人口存在维生素 B12 缺乏症的风险。 由于老年人缺乏饮食和营养摄入，维生素缺乏症在 60 岁以上的人群中呈上升趋势。 例如，根据 BMC Geriatrics 上发表的一篇论文，缺铁性贫血 (IDA) 是与贫血相关的最常见营养缺乏症，其次是维生素 B12、叶酸和老年人中的铁。我来了。 上述消息来源还指出，静脉补铁可增加血红蛋白 (Hb) 水平，并减少患有 IDA 的老年手术患者对输血的需求。 因此，对住院患者有静脉补剂的需求。

此外，老龄化社会正在快速推进，预计未来还会进一步增加。 例如，根据世界卫生组织2021年10月更新的数据，据说到2030年，全球每6人中就有1人超过60岁。 届时，60岁以上人口将从2020年的10亿增长到14亿。 到 2050 年，全球 60 岁及以上人口预计将翻一番，达到 21 亿。 因此，老年人口的增长和该人群维生素缺乏症的负担预计将为静脉补充剂和维生素创造机会。 预计这将在预测期内创造对 IV 极的需求并推动市场增长。

此外，主要参与者推出的新产品和活动预计将推动市场增长。 例如，2022 年 4 月，FDA 将要求住院成人接受全身性皮质类固醇并需要补充氧气、无创或有创机械通气或体外膜肺氧合 (ECMO)。 COVID-19 的治疗 因此，这种市场发展预计将产生对 IV 极的需求，用于对患者进行药物或治疗管理，并在预测期内推动市场增长。

因此，由于上述因素，市场有望在预测期内出现增长。 然而，传统 IV 极带来的挑战预计将在预测期内略微阻碍市场增长。

输液桿市场趋势

预计在预测期内医院和诊所的销售额将增长

医院和诊所配备了先进的技术设备来管理患者。 医疗设施的基础设施发展和新兴国家政府组织的支持正在推动 IV 极市场的增长。 此外，患者数量的增加也对该行业产生了积极影响。

此外，输液架是一种用于固定装有药物和液体的输液袋的装置。 它被用作医院的标准设备。 将输液袋挂在桿顶的挂钩上。 然后，通过将必要的输液用管子连接到患者的静脉，可以安全有效地进行输液。 这样，随着住院病人的增多，输液架的需求量越来越大，用于静脉滴註生理盐水、静脉注射维生素等各种用途。 例如，根据AIHW 2022年5月公布的数据，2020-21年澳大利亚住院患者人数约为1180万，较2019-20年增长6.3%。 在 1180 万住院患者中，7.0% 是在重症监护病房，3.8% 是因为心血管疾病。 急诊和重症监护入院人数的增加产生了对静脉内补充剂的需求。 因此，上述因素有望推动该分部的增长。

此外，医院数量的增加是促进该细分市场增长的另一个因素。 根据美国心臟协会发布的统计报告，2020年美国有2946家非政府、非营利性社区医院，2022年增加到2960家。 医院数量的增加创造了对医院输液架的需求。 因此，预计将推动该板块的增长。

因此，由于上述因素，预计该细分市场在预测期内将出现增长。

北美预计在预测期内增长

北美目前占据主要市场份额，预计未来几年仍将如此。 由于医疗保健支出增加和慢性病负担增加，预计美国将在其他国家中保持重要的市场份额。

此外，预计美国医疗保健支出的上升趋势也将推动市场增长。 美国政府和人民每年在医疗保健上花费数百万美元。 例如，根据经合组织公布的卫生支出统计数据，美国人均自愿医疗费用为1807美元，自付费用医疗费用也有所增加，据报导为每人1225美元。 因此，预计更高的医疗保健支出将增加医院发展活动和各种慢性病的住院率。 同时，它将推动医院、诊所和其他终端用户对输液架的需求。 因此，上述因素有望推动市场增长。

此外，在日本，癌症等慢性病的发病率和患病率正在上升。 根据美国癌症协会的数据，2021 年新发白血病病例估计约为 61,090 例，而 2020 年为 60,530 例。 随着癌症患者人数的增加，癌症患者的住院和输液治疗次数也将增加，这有望推动市场的增长。

随着癌症患者的增加，输液疗法的发展在日本不断进步。 例如，2022 年 8 月，FDA 批准了 Enhertu（famtrastuzumab 和 derquistecan-nxki）用于静脉输注作为治疗不可切除（unresectionable）或转移性（metastatic）HER2-low 乳腺癌患者。）”已经获批。 由于此类治疗方法的发展，需要在滴注过程中使用滴液桿。 因此，这有望推动市场增长。

因此，上述因素被认为有助于北美 IV 极市场的增长。

静脉极市场竞争对手分析

输电线桿市场竞争适中，由几家大型企业组成。 目前主导市场的公司包括 3M、Cardinal Health、medifa、Promotal、Alvo、Villard、Antano Group、Savion、Zakad Techniki Medicznej TECH-MED Sp. z o. o.、Besco Medical。

其他好处

  • Excel 格式的市场预测 (ME) 表
  • 三个月的分析师支持

内容

第1章介绍

  • 研究假设和市场定义
  • 调查范围

第2章研究方法论

第 3 章执行摘要

第4章市场动态

  • 市场概览
  • 市场驱动因素
    • 消化系统疾病、神经系统疾病和癌症等疾病增加
    • 老年人口增加
  • 市场製约因素
    • 传统电线桿面临的挑战
  • 波特的五力分析
    • 新进入者的威胁
    • 买方/消费者议价能力
    • 供应商的议价能力
    • 替代品的威胁
    • 竞争公司之间的敌对关係

第 5 章市场细分（基于价值的市场规模：100 万美元）

  • 按产品类型
    • 2 钩顶
    • 4 钩顶
    • 6 钩顶
    • 8 钩顶
  • 按材料
    • 不銹钢
    • 镀铬钢
    • 其他材料
  • 最终用户
    • 医院和诊所
    • 门诊手术中心
    • 其他最终用户
  • 按地区细分
    • 北美
      • 美国
      • 加拿大
      • 墨西哥
    • 欧洲
      • 德国
      • 英国
      • 法国
      • 意大利
      • 西班牙
      • 其他欧洲地区
    • 亚太地区
      • 中国
      • 日本
      • 印度
      • 澳大利亚
      • 韩国
      • 其他亚太地区
    • 世界其他地区

第6章竞争格局

  • 公司简介
    • 3M
    • Cardinal Health
    • medifa-hesse GmbH & Co. KG
    • Promotal SAS
    • Villard
    • Antano Group
    • Savion LLC
    • Tech-Med Sp. z.o.o. Department of Medical Technology
    • Besco Medical
    • Bristol Maid
    • COMED
    • Mid Central Medical
    • ALVO Medical

第7章 市场机会与今后动向

简介目录
Product Code: 68596

The IV poles market is projected to register a CAGR of 6.3% during the forecast period.

The COVID-19 pandemic had a short-term negative impact on the market due to decreased patient visits to hospitals and clinics in the initial phases. However, during the later phases of the pandemic, the demand for research and clinical trials increased to find out if intravenous (IV) injections and supplements helped escalate the symptoms of COVID-19 in infected patients. For instance, the COVID-19 treatment guideline that the NIH updated in September 2022 mentioned that when patients were randomized to receive IV vitamin C (50 mg/kg per day) with standard therapy or standard therapy such as antipyretics, dexamethasone and prophylactic antibiotics in an open-label trial of hospitalized patients with severe COVID-19 in Pakistan, those who got vitamin C experienced earlier symptom remission and shorter hospital stays than those who just received standard therapy. Thus, these instances during the pandemic created a demand for IV treatments, ultimately generating opportunities for the IV poles market. Therefore, owing to the abovementioned factors and instances, the COVID-19 pandemic significantly impacted the market studied.

Factors like increasing chronic diseases, such as cancer, neurological diseases, and gastrointestinal disorders, and an increase in the geriatric population contribute to the growth of the IV poles market.

The population is aging globally, ultimately increasing the disease burden. Various research suggests that more than 20% of the geriatric population is at risk of vitamin B12 deficiency. Due to insufficient intake of food and nutrition at an older age, vitamin deficiency increases among the elderly population aged 60 years or more. For instance, according to an article published in the BMC Geriatrics journal, iron deficiency anemia (IDA) is the most common type of nutrient deficit linked with anemia, followed by vitamin B12, folate, and iron in the older population. Additionally, the above source also stated that, in elderly surgical patients with IDA, intravenous iron supplementation raises hemoglobin (Hb) levels and lowers the need for blood transfusions. Thus, there is a demand for IV supplements among hospitalized patients.

In addition, the aging population is increasing rapidly, and it is expected to increase more quickly in the future. For instance, the data updated by the WHO in October 2021 shows that one in six individuals will be 60 or older by 2030 globally. By this time, there will be 1.4 billion people over 60, up from 1 billion in 2020. The number of people around the globe who are 60 years or older will double to 2.1 billion by 2050. Thus, the increasing geriatric population, coupled with the burden of vitamin deficiency among this population, is expected to create opportunities for IV supplements and vitamins. This is projected to generate demand for IV poles, thus driving the growth of the market over the forecast period.

Furthermore, the introduction of new products and activities by major players is predicted to fuel the growth of the market. For instance, in April 2022, the FDA granted priority review to Genentech's Actemra (tocilizumab) intravenous (IV) for the treatment of COVID-19 in hospitalized adults receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ECMO). Thus, such developments are expected to generate demand for IV poles for drug or therapy administration to patients and drive the growth of the market over the forecast period.

Therefore, the market is expected to witness growth over the forecast period due to the factors mentioned above. However, the challenges faced by conventional IV poles are anticipated to hamper the growth of the market slightly during the forecast period.

IV Poles Market Trends

The Hospitals and Clinics Segment is Expected to Witness Growth During the Forecast Period

Hospitals and clinics are well-equipped with advanced technological equipment for patient management. The improving infrastructure of healthcare facilities in emerging economies and support from government organizations fuel the growth of the segment in the IV poles market. Furthermore, the increasing pool of patients also has a positive effect on this segment.

Additionally, IV poles are equipment that hold IV bags filled with medicine or fluid in place. They are a standard component of hospital operations. The hooks at the top of the pole are used to hang the bags. The necessary fluids are then securely and effectively delivered by connecting them via a tube into the patient's veins. Thus, with increasing numbers of hospital admissions, the demand for IV poles is growing for various applications, such as IV saline and IV vitamin therapy. For instance, according to the data published by the AIHW in May 2022, about 11.8 million hospital admissions occurred in Australia in 2020-21, which is 6.3% more compared to 2019-20. It also reported that out of 11.8 million admissions, 7.0% of hospitalizations involved a stay in the intensive care unit, and 3.8% of hospitalizations involved cardiovascular disease. Such increasing admissions to emergency and critical care generate the need for IV supplements. Thus, the abovementioned factors are expected to drive the growth of the segment.

Furthermore, the increasing number of hospitals is another factor that contributes to the growth of the segment. According to the statistics report published by the AHA, there were 2,946 non-government, not-for-profit community hospitals in the United States in 2020, which increased to 2,960 in 2022. This increase in the number of hospitals creates a demand for IV poles in hospital settings. Hence, it is expected to boost the growth of the segment.

Therefore, owing to the abovementioned factors, the segment is expected to witness growth over the forecast period.

North America is Expected to Witness Growth During the Forecast Period

North America currently holds a major market share, and it is expected to continue its stronghold for a few more years. The United States is expected to retain its significant market share among other countries, owing to rising healthcare expenditure and the increasing burden of chronic diseases.

The increasing trend of rising healthcare expenditures in the United States is also predicted to propel market growth. The US government and the population spend a significant amount on healthcare every year. For instance, the health spending statistics published by the OECD reported that in the United States, voluntary healthcare spending per capita accounted for USD 1,807, and out-of-pocket spending on healthcare also increased, which accounted for USD 1,225 per capita. Thus, high expenditure on healthcare is anticipated to increase hospital development activities and hospital admissions for various chronic diseases. Simultaneously, it will generate demand for IV poles used in hospitals, clinics, and other end users. Therefore, the abovementioned factors are expected to drive the growth of the market.

Furthermore, the incidence and prevalence of chronic diseases like cancer are increasing in the country. According to the American Cancer Society, there were around 61,090 new estimated cases of leukemia in 2021, compared to 60,530 in 2020. As cancer cases increase, hospital admissions and IV therapies for cancer patients will also increase, driving the growth of the market.

With the increase in cancer cases, the development of IV therapies is also increasing in the country. For instance, in August 2022, the FDA approved Enhertu (fam-trastuzumab-deruxtecan-nxki), an IV infusion, for the treatment of patients with unresectable (unable to be removed) or metastatic (spread to other parts of the body) HER2-low breast cancer. This development of therapies is creating demand for the availability of IV poles used during infusion. Hence, this is expected to fuel the growth of the market.

Therefore, the abovementioned factors are expected to contribute to the growth of the market for IV poles in North America.

IV Poles Market Competitor Analysis

The IV Poles market is moderately competitive and consists of several major players. Some companies that are currently dominating the market are 3M, Cardinal Health, medifa, Promotal, Alvo, Villard, Antano Group, Savion, Zakad Techniki Medycznej TECH-MED Sp. z o. o., and Besco Medical.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing Prevalence of Diseases, such as Gastrointestinal Disorder, Neurological Diseases, Cancer
    • 4.2.2 Increasing Geriatric Population
  • 4.3 Market Restraints
    • 4.3.1 Challenges Faced by The Conventional Poles
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION (Market Size by Value - USD million)

  • 5.1 By Product Type
    • 5.1.1 2 Hook Top
    • 5.1.2 4 Hook Top
    • 5.1.3 6 Hook Top
    • 5.1.4 8 Hook Top
  • 5.2 By Material
    • 5.2.1 Stainless Steel
    • 5.2.2 Chrome-plated Steel
    • 5.2.3 Other Materials
  • 5.3 By End User
    • 5.3.1 Hospitals and Clinics
    • 5.3.2 Ambulatory Surgical Centers
    • 5.3.3 Other End Users
  • 5.4 By Geography
    • 5.4.1 North America
      • 5.4.1.1 United States
      • 5.4.1.2 Canada
      • 5.4.1.3 Mexico
    • 5.4.2 Europe
      • 5.4.2.1 Germany
      • 5.4.2.2 United Kingdom
      • 5.4.2.3 France
      • 5.4.2.4 Italy
      • 5.4.2.5 Spain
      • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia-Pacific
      • 5.4.3.1 China
      • 5.4.3.2 Japan
      • 5.4.3.3 India
      • 5.4.3.4 Australia
      • 5.4.3.5 South Korea
      • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Rest of the World

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 3M
    • 6.1.2 Cardinal Health
    • 6.1.3 medifa-hesse GmbH & Co. KG
    • 6.1.4 Promotal SAS
    • 6.1.5 Villard
    • 6.1.6 Antano Group
    • 6.1.7 Savion LLC
    • 6.1.8 Tech-Med Sp. z.o.o. Department of Medical Technology
    • 6.1.9 Besco Medical
    • 6.1.10 Bristol Maid
    • 6.1.11 COMED
    • 6.1.12 Mid Central Medical
    • 6.1.13 ALVO Medical

7 MARKET OPPORTUNITIES AND FUTURE TRENDS